Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Apr 7, 2023 | How Biotech And Other Industries Can Find Balance In A Hybrid Work Model | Leen Kawas | Entrepreneur, Inventor, Innovator and Leader | Managing General Partner at Propel Bio Partners. |
| Oct 4, 2022 | Leen Kawas, Ph.D., Accepted into Forbes Business Council | Leen Kawas, Ph.D. “I look forward to collaborating with other members of the Council, sharing my experiences and hands-on expertise with the Forbes community, and continuing to grow alongside other leaders and experts in the Forum.” LOS ANG... |
| Sep 6, 2022 | Inherent Biosciences raises funding to expand fertility care though epigenetics | Epigenetics is the study of how behaviors and environment can cause changes to the way genes work One in eight couples have trouble getting pregnant, and the reasons for that can be varied, yet fertility is still thought of mostly as women&... |
| Ex-Athira Pharma CEO Leen Kawas Starts $150M Fund With Key Investors From Former Company | Leen Kawas, the Seattle biotech exec who resigned as CEO of Athira Pharma after an investigation found she had altered doctoral research images that helped to form the initial basis for the company, re-emerged Friday as co-founder and manag... |
Reviews 0
FAQ about Propel Bio Partners
What has the press written about Propel Bio Partners?
Parsers VC has collected 5 articles mentioning Propel Bio Partners, among them “How Biotech And Other Industries Can Find Balance In A Hybrid Work Model” (Apr 7, 2023) and “Leen Kawas, Ph.D., Accepted into Forbes Business Council” (Oct 4, 2022).
Is Propel Bio Partners still active?
Yes, Propel Bio Partners is active; its latest activity on Parsers VC dates from Nov 30, 2023.